// App-Quantinova.ai

3589 : Nucleotide excision repair is elevated in stage IV commonly used breast cancer cell lines as compared to stage I breast tumor explants

Researchers

Presenter

  • Homood As Sobeai

Principal Investigators

  • Jennifer M. Johnson

  • Nancy Lalanne

  • Omar Ibrahim

  • Stephen G. Grant

  • Sharon L. Wenger

  • Jean J. Latimer

Medical Centers

  • Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL.

  • Thomas Jefferson University, Philadelphia, PA

  • Case Western Reserve University, Cleveland, OH

  • West Virginia University, Morgantown, WV

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • BT-20

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved